Endo Pharmaceuticals, Inc. is recalling 2,856 bottles of Robaxin-750 (methocarbamol tablets, USP), 750 mg, in 100-count bottles. The labels on these bottles incorrectly instruct patients to take "Two to four tablets four times daily" when the correct dosage should be "Two tablets three times daily." This labeling error could lead consumers to take a much higher dose than intended, which may be unsafe.
Following the incorrect instructions on the label could result in an accidental overdose of methocarbamol. This medication is a muscle relaxant, and taking too much can cause symptoms such as extreme drowsiness, dizziness, or other serious health complications.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.